|
|
|
Insider
Information: |
Ingram Robert Alexander |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
516,452 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,023,966 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
516,452 |
|
|
Total
Value |
$6,023,966 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
2.0
|
Percentage
Gain/Loss : |
-59.5%
|
33.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Edwards Lifesciences Corp |
EW |
Director |
2015-05-15 |
32,367 |
2004-05-13 |
0 |
Premium* |
|
Lowes Companies Inc |
LOW |
Director |
2010-05-27 |
0 |
2005-05-27 |
0 |
Premium* |
|
Wolfspeed |
WOLF |
Director |
2018-10-17 |
77,710 |
2008-12-29 |
0 |
Premium* |
|
Bausch Health Companies Inc |
BHC |
Director |
2017-03-31 |
92,046 |
2010-09-28 |
0 |
Premium* |
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-05-18 |
0 |
Premium* |
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2015-05-27 |
1,500 |
2015-05-22 |
0 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-02-28 |
100,198 |
2016-09-01 |
0 |
Premium* |
|
Novan, Inc. |
NOVN |
Director |
2019-05-22 |
169,777 |
|
0 |
Premium* |
|
Black Diamond Therapeutics, Inc. |
BDTX |
|
2022-12-16 |
42,854 |
2020-09-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2017-03-02 |
4 |
A |
$6.24 |
$9,996 |
D/D |
1,602 |
5,823 |
0 |
- |
|
BHC |
Bausch Health Companies I... |
Director |
|
2017-03-31 |
4 |
A |
$11.03 |
$23,384 |
D/D |
2,120 |
92,046 |
0 |
- |
|
WOLF |
Wolfspeed |
Director |
|
2017-04-26 |
4 |
A |
$22.07 |
$24,983 |
D/D |
1,132 |
61,816 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2017-06-01 |
4 |
A |
$5.15 |
$9,996 |
D/D |
1,941 |
7,764 |
0 |
- |
|
WOLF |
Wolfspeed |
Director |
|
2017-08-23 |
4 |
A |
$22.21 |
$24,986 |
D/D |
1,125 |
62,941 |
0 |
- |
|
NOVN |
Novan, Inc. |
Director |
|
2017-08-25 |
4 |
B |
$4.25 |
$15,024 |
D/D |
3,535 |
61,312 |
2.39 |
- |
|
NOVN |
Novan, Inc. |
Director |
|
2017-08-29 |
4 |
B |
$4.70 |
$39,786 |
D/D |
8,465 |
69,777 |
2.39 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2017-09-01 |
4 |
A |
$5.10 |
$18,748 |
D/D |
3,676 |
11,440 |
0 |
- |
|
WOLF |
Wolfspeed |
Director |
|
2017-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,033 |
69,974 |
0 |
- |
|
WOLF |
Wolfspeed |
Director |
|
2017-10-18 |
4 |
A |
$34.16 |
$24,971 |
D/D |
731 |
70,705 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2017-12-01 |
4 |
A |
$5.08 |
$18,745 |
D/D |
3,690 |
15,130 |
0 |
- |
|
WOLF |
Wolfspeed |
Director |
|
2018-01-24 |
4 |
A |
$35.98 |
$29,971 |
D/D |
833 |
71,538 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2018-03-01 |
4 |
A |
$4.97 |
$18,747 |
D/D |
3,772 |
18,902 |
0 |
- |
|
WOLF |
Wolfspeed |
Director |
|
2018-04-25 |
4 |
A |
$39.25 |
$29,987 |
D/D |
764 |
72,302 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2018-06-01 |
4 |
A |
$6.43 |
$18,750 |
D/D |
2,916 |
21,818 |
0 |
- |
|
WOLF |
Wolfspeed |
Director |
|
2018-08-15 |
4 |
A |
$46.26 |
$29,976 |
D/D |
648 |
72,950 |
0 |
- |
|
WOLF |
Wolfspeed |
Director |
|
2018-08-30 |
4 |
OE |
$30.92 |
$123,680 |
D/D |
4,000 |
76,950 |
0 |
- |
|
NOVN |
Novan, Inc. |
Director |
|
2018-09-28 |
4 |
B |
$2.84 |
$142,000 |
D/D |
50,000 |
119,777 |
2.39 |
- |
|
WOLF |
Wolfspeed |
Director |
|
2018-10-17 |
4 |
A |
$39.46 |
$29,990 |
D/D |
760 |
77,710 |
0 |
- |
|
NOVN |
Novan, Inc. |
Director |
|
2019-05-22 |
4 |
B |
$2.21 |
$110,500 |
D/D |
50,000 |
169,777 |
2.39 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2019-09-01 |
4 |
A |
$2.99 |
$18,747 |
D/D |
6,270 |
28,088 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2019-11-18 |
4 |
B |
$1.45 |
$29,000 |
D/D |
20,000 |
48,088 |
2.39 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2019-12-01 |
4 |
A |
$2.85 |
$18,747 |
D/D |
6,578 |
54,666 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2020-03-01 |
4 |
A |
$3.00 |
$18,750 |
D/D |
6,250 |
60,916 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2020-06-01 |
4 |
A |
$4.50 |
$18,749 |
D/D |
4,171 |
65,087 |
0 |
- |
|
145 Records found
|
|
Page 5 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|